« Back to Record
Citation APA

Debiasi, M., Guindalini, R. S. C. R., Filho, P., Albuquerque, C., Reinert, T., de Azambuja, E., Olopade, O., Polanczyk, C. A., Ziegelmann, P. K., Barrios, C. H., Cao, H., Dignam, J. J., Goss, P. E., Bychkovsky, B., & Finkelstein, D. D. (2018). Efficacy of anti-HER2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced HER2-positive breast cancer patients: A network meta-analysis. Frontiers in oncology, 8(MAY), 156. doi:10.3389/fonc.2018.00156


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/271385

Debiasi, M., Guindalini, R. S. C. R., Filho, P., Albuquerque, C., Reinert, T., de Azambuja, E., Olopade, O., Polanczyk, C. A., Ziegelmann, P. K., Barrios, C. H., Cao, H., Dignam, J. J., Goss, P. E., Bychkovsky, B., & Finkelstein, D. D. (2018). Efficacy of anti-HER2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced HER2-positive breast cancer patients: A network meta-analysis. Frontiers in oncology, 8(MAY), 156. doi:10.3389/fonc.2018.00156